LncRNA AK054921 and AK128652 are potential serum biomarkers and predictors of patient survival with alcoholic cirrhosis

Hepatology Communications

Volumn 1, Issue 6, 2017, Pages 513-523

  Yang, Zhihong ^a,b   Ross, Ruth A ^c   Zhao, Shi ^d   Tu, Wanzhu ^d   Liangpunsakul, Suthat ^c,e   Wang, Li ^a,b,f,g  

^a UNIVERSITY OF CONNECTICUT   (United States)

^b VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Richard M Fairbanks School of Public Health   (United States)

^e RICHARD L ROUDEBUSH VETERANS AFFAIRS MEDICAL CENTER   (United States)

^f YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g WENZHOU MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

LNCRNA AK054921; LNCRNA AK1218652; LONG UNTRANSLATED RNA; UNCLASSIFIED DRUG;

ALCOHOL CONSUMPTION; ALCOHOL LIVER CIRRHOSIS; ARTICLE; CHILD PUGH SCORE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; EXPLORATORY RESEARCH; HUMAN; HUMAN TISSUE; LIVER TISSUE; OVERALL SURVIVAL; PLASMA; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE; TRANSCRIPTOMICS;

EID: 85045636381     PISSN: None     EISSN: 2471254X     Source Type: Journal    
DOI: 10.1002/hep4.1061     Document Type: Article

References (35)

1. Rehm J, Samokhvalov AV, Shield KD. Global burden of alcoholic liver diseases. J Hepatol 2013;59:160-168
2. Liangpunsakul S, Haber P, McCaughan GW. Alcoholic liver disease in Asia, Europe, and North America. Gastroenterology 2016;150:1786-1797
3. Lieber CS, Jones DP, Decarli LM. Effects of prolonged ethanol intake: production of fatty liver despite adequate diets. J Clin Invest 1965;44:1009-1021
4. Mills SJ, Harrison SA. Comparison of the natural history of alcoholic and nonalcoholic fatty liver disease. Curr Gastroenterol Rep 2005;7:32-36
5. Li TK. Quantifying the risk for alcohol-use and alcohol-attributable health disorders: present findings and future research needs. J. Gastroenterol Hepatol 2008;23(Suppl 1):S2-S8
6. Järveläinen HA, Orpana A, Perola M, Savolainen VT, Karhunen PJ, Lindros KO. Promoter polymorphism of the CD14 endotoxin receptor gene as a risk factor for alcoholic liver disease. Hepatology 2001;33:1148-1153
7. Watanabe J, Hayashi S, Kawajiri K. Different regulation and expression of the human CYP2E1 gene due to the RsaI polymorphism in the 5′-flanking region. J Biochem 1994;116:321-326
8. Yang Z, Tsuchiya H, Zhang Y, Lee S, Liu C, Huang Y, et al. REV-ERBα activates C/EBP homologous protein to control small heterodimer partner-mediated oscillation of alcoholic fatty liver. Am J Pathol 2016;186:2909-2920
9. Romeo S, Kozlitina J, Xing C, Pertsemlidis A, Cox D, Pennacchio LA, et al. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat Genet 2008;40:1461-1465
10. Tian C, Stokowski RP, Kershenobich D, Ballinger DG, Hinds DA. Variant in PNPLA3 is associated with alcoholic liver disease. Nat Genet 2010;42:21-23
11. Stickel F, Buch S, Lau K, Meyer zu Schwabedissen H, Berg T, Ridinger M, et al. Genetic variation in the PNPLA3 gene is associated with alcoholic liver injury in Caucasians. Hepatology 2011;53:86-95
12. Tran M, Yang Z, Liangpunsakul S, Wang L. Metabolomics analysis revealed distinct cyclic changes of metabolites altered by chronic ethanol-plus-binge and Shp deficiency. Alcohol Clin Exp Res 2016;40:2548-2556
13. Szabo G, Bala S. MicroRNAs in liver disease. Nat Rev Gastroenterol Hepatol 2013;10:542-552
14. Takahashi K, Yan I, Haga H, Patel T. Long noncoding RNA in liver diseases. Hepatology 2014;60:744-753
15. Zhang L, Yang Z, Trottier J, Barbier O, Want L. LncRNA MEG3 induces cholestatic liver injury by interaction with PTBP1 to facilitate Shp mRNA decay. Hepatology 2017;65:604-615
16. Zhang Y, Liu C, Barbier O, Smalling R, Tsuchiya H, Lee S et al. Bcl2 is a critical regulator of bile acid homeostasis by dictating Shp and lncRNA H19 function. Sci Rep 2016;6:20559
17. Chen Z. Progress and prospects of long noncoding RNAs in lipid homeostasis. Mol Metab 2016;5:164-170
18. Chen G, Yu D, Nian X, Liu J, Koenig RJ, Xu B, et al. LncRNA SRA promotes hepatic steatosis through repressing the expression of adipose triglyceride lipase (ATGL). Sci Rep 2016;6:35531
19. Whitfield JB, Rahman K, Haber PS, Day CP, Masson S, Daly AK, et al. Brief report: genetics of alcoholic cirrhosis-GenomALC multinational study. Alcohol Clin Exp Res 2015;39:836-842
20. Cutright P, Fernquist RM. Predictors of per capita alcohol consumption and gender-specific liver cirrhosis mortality rates: thirteen European countries, circa 1970-1984 and 1995-2007. Omega (Westport) 2010;62:269-283
21. Zhang Y, Xu N, Xu J, Kong B, Copple B, Guo GL, et al. E2F1 is a novel fibrogenic gene that regulates cholestatic liver fibrosis through the Egr-1/SHP/EID1 network. Hepatology 2014;60:919-930
22. Smalling RL, Delker DA, Zhang Y, Nieto N, McGuiness MS, Liu S, et al. Genome-wide transcriptome analysis identifies novel gene signatures implicated in human chronic liver disease. Am J Physiol Gastrointest Liver Physiol 2013;305:G364-G374
23. Vance KW, Ponting CP. Transcriptional regulatory functions of nuclear long noncoding RNAs. Trends Genet 2014;30:348-355
24. Cao J. The functional role of long non-coding RNAs and epigenetics. Biol Proced Online 2014;16:11
25. Li SY, Susztak K. The long noncoding RNA Tug1 connects metabolic changes with kidney disease in podocytes. J Clin Invest 2016;126:4072-4075
26. Caputa G, Schaffer JE. RNA Regulation of lipotoxicity and metabolic stress. Diabetes 2016;65:1816-1823
27. Reddy MA, Chen Z, Park JT, Wang M, Lanting L, Zhang Q, et al. Regulation of inflammatory phenotype in macrophages by a diabetes-induced long noncoding RNA. Diabetes 2014;63:4249-4261
28. Song Y, Liu C, Liu X, Trottier J, Beaudoin M, Zhang L, et al. H19 promotes cholestatic liver fibrosis by preventing ZEB1-mediated inhibition of EpCAM. Hepatology 2017; doi: 10.1002/hep.29209
29. Ma X, Wang X, Yang C, Wang Z, Han B, Wu L, et al. DANCR Acts as a diagnostic biomarker and promotes tumor growth and metastasis in hepatocellular carcinoma. Anticancer Res 2016;36:6389-6398
30. Lai MC, Yang Z, Zhou L, Zhu QQ, Xie HY, Zhang F, et al. Long non-coding RNA MALAT-1 overexpression predicts tumor recurrence of hepatocellular carcinoma after liver transplantation. Med Oncol 2012;29:1810-1816
31. Zhu H, Zhang L, Yan S, Li W, Cui J, Zhu M, et al. LncRNA16 is a potential biomarker for diagnosis of early-stage lung cancer that promotes cell proliferation by regulating the cell cycle. Oncotarget 2017;8:7867-7877
32. Zhang Y, Yang R, Lian J, Xu H. LncRNA Sox2ot overexpression serves as a poor prognostic biomarker in gastric cancer. Am J Transl Res 2016;8:5035-5043
33. Gao B. Basic liver immunology. Cell Mol Immunol 2016;13:265-266
34. Wang M, You Q, Lor K, Chen F, Gao B, Ju C. Chronic alcohol ingestion modulates hepatic macrophage populations and functions in mice. J Leukoc Biol 2014;96:657-665
35. Gao B, Bataller R. Alcoholic liver disease: pathogenesis and new therapeutic targets. Gastroenterology 2011;141:1572-1585